Trial Profile
Special Drug Use-results survey for long-term administration of Stelara
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2019
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Plaque psoriasis; Psoriatic arthritis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen Pharmaceutical KK
- 13 Dec 2018 Status changed from active, no longer recruiting to completed.
- 16 Dec 2014 New trial record